Corcept Therapeutics Incorporated shares owned by Swiss National Bank
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Swiss National Bank
from 13F filings
Historical chart of Swiss National Bank investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Corcept Therapeutics Incorporated by Swiss National Bank
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $8.5M | 183k | 46.28 |
2024-06-30 | $6.0M | 183k | 32.49 |
2024-03-31 | $4.4M | 173k | 25.19 |
2023-12-31 | $5.6M | 172k | 32.48 |
2023-09-30 | $5.2M | 190k | 27.25 |
2023-06-30 | $4.2M | 188k | 22.25 |
2023-03-31 | $4.5M | 209k | 21.66 |
2022-12-31 | $4.7M | 233k | 20.31 |
2022-09-30 | $5.8M | 227k | 25.64 |
2022-06-30 | $5.3M | 225k | 23.78 |
2022-03-31 | $5.8M | 259k | 22.52 |
2021-12-31 | $4.8M | 243k | 19.80 |
2021-09-30 | $4.8M | 246k | 19.68 |
2021-06-30 | $5.4M | 246k | 22.00 |
2021-03-31 | $6.0M | 252k | 23.79 |
2020-12-31 | $6.5M | 248k | 26.16 |
2020-09-30 | $4.3M | 247k | 17.41 |
2020-06-30 | $4.1M | 243k | 16.82 |
2020-03-31 | $2.4M | 200k | 11.89 |
2019-12-31 | $2.4M | 196k | 12.10 |
2019-09-30 | $2.7M | 194k | 14.14 |
2019-06-30 | $2.1M | 192k | 11.15 |
2019-03-31 | $2.2M | 189k | 11.74 |
2018-12-31 | $2.5M | 185k | 13.36 |
2018-09-30 | $2.5M | 179k | 14.02 |
2018-06-30 | $2.8M | 179k | 15.72 |
2018-03-31 | $2.4M | 148k | 16.45 |
2017-12-31 | $2.6M | 143k | 18.06 |
2017-09-30 | $2.7M | 139k | 19.30 |
2017-06-30 | $1.6M | 139k | 11.80 |
2017-03-31 | $1.4M | 128k | 10.96 |
2016-12-31 | $931k | 128k | 7.26 |
2016-09-30 | $833k | 128k | 6.50 |
2016-06-30 | $700k | 128k | 5.46 |
2016-03-31 | $500k | 111k | 4.52 |
2015-12-31 | $452k | 91k | 4.98 |
2015-09-30 | $341k | 91k | 3.76 |
2015-06-30 | $460k | 77k | 6.01 |
2013-09-30 | $155k | 98k | 1.59 |
2013-06-30 | $169k | 98k | 1.73 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated